Richard Christopher
2021 - InVivo Therapeutics Holdings
In 2021, Richard Christopher earned a total compensation of $697.8K as Chief Financial Officer at InVivo Therapeutics Holdings, a 25% increase compared to previous year.
Compensation breakdown
| Bonus | $254,569 |
|---|---|
| Option Awards | $69,633 |
| Salary | $355,212 |
| Other | $18,422 |
| Total | $697,836 |
Christopher received $355.2K in salary, accounting for 51% of the total pay in 2021.
Christopher also received $254.6K in bonus, $69.6K in option awards and $18.4K in other compensation.
Rankings
In 2021, Richard Christopher's compensation ranked 9,900th out of 12,415 executives tracked by ExecPay. In other words, Christopher earned more than 20.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,900 out of 12,415 | 20th |
Division Manufacturing | 4,380 out of 5,501 | 20th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 587 out of 801 | 27th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 378 out of 522 | 28th |
Industry Surgical and Medical Instruments and Apparatus | 238 out of 327 | 27th |
Source: SEC filing on August 18, 2022.
Christopher's colleagues
We found one more compensation record of an executive who worked with Richard Christopher at InVivo Therapeutics Holdings in 2021.
2021
Richard Toselli
InVivo Therapeutics Holdings
Chief Executive Officer
News
InVivo Therapeutics Holdings CEO Richard Toselli's 2022 pay slips 11% to $960K
December 5, 2023
InVivo Therapeutics Holdings CEO Richard Toselli's 2021 pay jumps 30% to $1.1M
August 18, 2022
InVivo Therapeutics Holdings CEO Richard Toselli's 2020 pay falls 34% to $832K
May 18, 2021
InVivo Therapeutics Holdings CEO Richard Toselli's 2019 pay jumps 69% to $1.3M
June 22, 2020